Evidence map›Paper›PMID 39903812›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Lgals3 Promotes Calcium Oxalate Crystal Formation and Kidney Injury Through Histone Lactylation-Mediated FGFR4 Activation.

Zehua Ye, Yushi Sun, Songyuan Yang, Lei Li, Bojun Li, Yuqi Xia, Tianhui Yuan, Weimin Yu, Lijia Chen, Xiangjun Zhou and 1 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Lactate-Mediated Lysine Lactylation in Renal Fibrosis: Current Progress and Challenges.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Current issues in molecular biology · 2026
    Article
  9. Article
  10. Post‑translational modifications in diabetic kidney disease (Review).International journal of molecular medicine · 2026
    Review
  11. Review
  12. Review
  13. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  14. Review
  15. Article
  16. Article
  17. Lactate Metabolism and Protein Lactylation in Diabetic Kidney Disease: A Narrative Review.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zehua YeDepartment of Urology, Renmin hospital of Wuhan university, Wuhan, 430060, China.
Yushi SunDepartment of Urology, Renmin hospital of Wuhan university, Wuhan, 430060, China.
Songyuan YangDepartment of Urology, Renmin hospital of Wuhan university, Wuhan, 430060, China.
Lei LiDepartment of Urology, Renmin hospital of Wuhan university, Wuhan, 430060, China.
Bojun LiDepartment of Urology, Renmin hospital of Wuhan university, Wuhan, 430060, China.
Yuqi XiaDepartment of Urology, Renmin hospital of Wuhan university, Wuhan, 430060, China.
Tianhui YuanDepartment of Urology, Renmin hospital of Wuhan university, Wuhan, 430060, China.
Weimin YuDepartment of Urology, Renmin hospital of Wuhan university, Wuhan, 430060, China.
Lijia ChenDepartment of Urology, Renmin hospital of Wuhan university, Wuhan, 430060, China.
Xiangjun ZhouDepartment of Urology, Renmin hospital of Wuhan university, Wuhan, 430060, China.
Fan ChengDepartment of Urology, Renmin hospital of Wuhan university, Wuhan, 430060, China.ORCID https://orcid.org/0000-0002-3471-6221

Funding

National Natural Science Foundation of China 82100806National Natural Science Foundation of China 82170775National Natural Science Foundation of China 82270802National Natural Science Foundation of China 82272232National Natural Science Foundation of China 82300766National Natural Science Foundation of China 82370765
6 · The paper itself

Abstract

The incidence of kidney stones is increasing worldwide. However, the underlying mechanism of the process of kidney stone formation and the kidney damage caused are not well understood. Here, it is observed that Lgals3, a β-galactoside-binding protein, is significantly increased in tissues with calcium oxalate (CaOx) stones, and in both in vivo and in vitro models. Lgals3 expression is positively correlated with the deposition of CaOx crystals. Knockout of Lgals3 markedly reduces the deposition of CaOx crystal and renal fibrosis in vivo. Furthermore, Lgals3 deficiency decrease the glycolytic rate and lactate production during the process of CaOx deposition and inhibited histone lactylation of H3K18la. Mechanistic studies shows that Lgals3 directly interacted with the key glycolysis protein pyruvate kinase M2 (PKM2) and promoted its expression by modulating E3 ligase Trim21, preventing the ubiquitination of PKM2. Furthermore, H3K18 lactylation promoted CaOx crystal deposition and kidney injury in vivo and in vitro. Lgals3 deficiency inhibites the transcription, activation, and expression of FGFR4 through inhibition of H3K18la. These findings suggest that Lgals3 may play a key role in CaOx stone formation and kidney injury by interacting with PKM2 and promoting both H3K18la-mediated gene transcription and activation.

Indexed as

Calcium OxalateGalectin 3HistonesKidney CalculiReceptor, Fibroblast Growth Factor, Type 4AnimalsBlood ProteinsCrystallizationGalectinsHumansKidneyMaleMiceMice, Inbred C57BLMice, KnockoutBlood ProteinsCalcium OxalateGalectin 3GalectinsHistonesLGALS3 protein, humanLgals3 protein, mouseReceptor, Fibroblast Growth Factor, Type 4CaOx crystalepigeneticshistone lactylationkidney injuryLgals3

Identifiers

PMID39903812
PMCPMC11947994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.